Cucumber Mosaic Virus (CMV) is a plant infecting tripartite positive-strand RNA virus. In addition to three genomic and two known subgenomic RNAs, CMV strains of subgroup II (e.g. Q-CMV), but not subgroup I (e.g. Fny-CMV), produce and package a redundant RNA5 encompassing the 3′ 304-307 nucleotides of RNAs 2 and 3. The mechanism regulating RNA5 production and its role in CMV life cycle is unknown. In this study, transient expression of Q2 or Q3 by agroinfiltration into Nicotiana benthamiana plants resulted in efficient accumulation of RNA5 suggesting that its production is independent of CMV replication. Deletion and point mutations engineered into a highly conserved region (Box1) adjacent to the 5′ end of RNA5 identified sequences required for its efficient production. An experimental system, involving a chimera of Q3 (Q3B3) characterized by having a 3′ tRNA-like structure (3′TLS) from Brome mosaic virus (BMV) and RNA5 defective variants of Q1 (Q1Δ), Q2 (Q2Δ) and Q3B3 (Q3ΔB3), was used to evaluate in vivo the contribution of RNA5 in promoting RNA recombination. Generation of precise homologous recombinants was strictly dependent on sequence identity. When both parental RNAs carried the Box1, recombination occurred preferentially within the Box1. In contrast, generation of non-homologous recombinants occurred only when Q1 and Q2 were competent to produce RNA5. A mechanistic model explaining the functional role played by the RNA5 in generating CMV recombinants was presented.
Introduction
Cucumber Mosaic Virus (CMV) is the type member of the genus Cucumovirus and belongs to the Bromoviridae family of plant viruses (Palukaitis and Garcia-Arenal, 2003) . The genome of CMV is divided among three single stranded, positive-sense RNAs. Viral RNA replication is dependent on efficient interaction between two nonstructural proteins, 1a and 2a, encoded by monocistronic RNA1 and RNA2, respectively (Boccard and Baulcombe, 1993) . Genomic RNA2 also encodes another protein, 2b that is expressed as a subgenomic RNA4A derived from progeny minus-sense RNA2 (Brigneti et al., 1998; Ding et al., 1994) . Protein 2b is the designated suppressor of post-transcriptional gene silencing (Brigneti et al.,1998) . Genomic RNA3 is dicistronic (Boccard and Baulcombe, 1993) . A nonstructural movement protein (MP) ORF encoded in the 5′ half is translated directly from RNA3. However, the 3′ ORF of the dicistronic RNA3 encoding coat protein (CP) is translationally silent and is synthesized from another subgenomic RNA4 derived from progeny minus-sense RNA3 (Boccard and Baulcombe, 1993) . Both MP and CP are dispensable for CMV replication but are required for whole plant infection (Boccard and Baulcombe, 1993; Canto et al., 1997; Palukaitis and Garcia-Arenal, 2003; Schmitz and Rao, 1998) . The 3′ end of all genomic and subgenomic RNAs terminate with a highly conserved multifunctional tRNA-like structure (TLS) that contains sequence elements necessary to initiate minus-strand synthesis by CMV replicase (Boccard and Baulcombe, 1993) .
According to molecular analyses of the genomic RNAs, CMV strains are classified into subgroups I and II (Palukaitis and Garcia-Arenal, 2003; Wahyuni et al., 1992) . A notable feature that distinguishes CMV strains of subgroup II and the closely related Tomato aspermy cucumovirus (TAV) from those strains of subgroup I, is the presence of an additional RNA species, referred to as RNA5 (Blanchard et al., 1996; Gould et al., 1978; Shi et al., 1997) . Sequence alignment of relevant 3′ non-coding regions from genomic RNAs of subgroup I and subgroup II CMV strains and TAV revealed that a 20 nt sequence motif, hereafter referred to as the Box1 (Fig. 1B) , is highly conserved in all CMV strains of subgroup II and TAV, but not in subgroup I (Blanchard et al., 1997; Shi et al., 1997) . Purified virions of subgroup II CMV strains have been shown to encapsidate RNA5 in addition to three genomic and two subgenomic RNAs (4 and 4A) (Palukaitis and Garcia-Arenal, 2003) .
Molecular characterization of Q-CMV RNA5 revealed that it is a mixture of the 3′ terminal 307 and 304 nt regions of RNAs 2 and 3, respectively (Blanchard et al., 1997; Shi et al., 1997) . Further biochemical characterization showed that RNA5 is most likely uncapped and could be phosphorylated at the 5′-end (Blanchard et al., 1997; Shi et al., 1997) . Early studies using kinetics of cDNA hybridizations to RNA5 led to the conclusion that it was derived through endonucleolytic cleavage of Q-CMV RNAs 1 to 4 (Blanchard et al., 1996; Gould et al., 1978) . Later on, it was suggested that RNA5 might have been generated as a subgenomic RNA from progeny minus RNA2 or RNA3 (Blanchard et al., 1997; Shi et al., 1997) . Experimental evidence in support of either mechanism remains elusive. A recent characterization of the structure-function relationship of the 5′ region of RNA5 revealed that mutations engineered into one of the four stem-loop structures encompassing a 21 nt conserved sequence of RNA5 (BoxI) affected its production in planta; furthermore deletion of this conserved sequence in CMV RNA3 had no detectable effect on accumulation of progeny RNA3 or its subgenomic RNA4 (Thompson et al., 2008) . However, their study did not address whether RNA5 is produced either through endonucleolytic cleavage or via replicationderived subgenomic RNA.
Using an Agrobacterium-mediated transient expression system, in this study we evaluated the mechanism of RNA5 production and its role in CMV recombination. Replication-independent expression of CMV genomic RNAs indicated that production of RNA5 is not contingent on viral replication and hence is not produced via subgenomic RNA synthesis. By controlling RNA5 production from acceptor and donor strands, results of our study accentuate the importance of RNA5 in generating recombinants of Q-CMV.
Results

Production of RNA5 is independent of replication
Previously studies speculated that RNA5 is produced via a subgenomic RNA synthesis mechanism (Blanchard et al., 1997; Shi et al., 1997) . This implies that production of RNA5 is replication dependent. To verify this possibility we assembled a series of T-DNA constructs of three Q-CMV genomic RNA (Fig. 1A) . Each agroconstruct was autonomously infiltrated into Nicotiana benthamiana leaves. As a positive control, parallel infiltrations were performed with a mixture of inoculum containing all three wt plasmids of CMV genomic RNA (i.e. Q1 + Q2 + Q3). Results of Northern blot hybridization of total RNA preparations isolated from infiltrated leaf samples are shown in Fig  1C. The replication competence of wt CMV genomic RNAs expressed from their respective agrotransformants was confirmed by the detection of two known subgenomic RNAs, 4 and 4A ( Fig. 1C ; lane 1). However, Northern blot analysis of total RNA preparations recovered from leaf samples infiltrated with individual genome components of Q-CMV displayed an unexpected profile. In the absence of replication, the accumulation levels of Q1 and Q2 were far below that of Q3 (Fig. 1C) . However, a faster migrating RNA with an electrophoretic mobility identical to that of RNA5 was consistently observed in leaves infiltrated with Q2 or Q3 but not Q1 (Fig. 1C , lanes 2-4). Since this faster migrating RNA species found in Q2 and Q3 samples was specifically hybridized with a probe complementary to the 3′ UTR region, we concluded that this species originated from the 3′ end of the respective genomic RNAs. In several repeated experiments we consistently observed that the efficiency of RNA5 production is higher for Q2 than Q3 (Fig. 1C, lanes 3 and 4) . To further confirm that this faster migrating RNA species was an authentic RNA5, total RNA of Q2 and Q3 samples were subjected to 5′RACE analysis. In each case, except for its first nucleotide, which is a U for Q2 and a G for Q3 (Fig. 1B) , the remaining sequence of the faster migrating RNA species was indistinguishable from that of RNA5 reported previously (Blanchard et al., 1996) . The position of the first nucleotide of RNA5 of Q2 and Q3 identified in this study is analogous to that of RNA5 of V-TAV RNA3 (Shi et al., 1997) . Based on this sequence data, the length of RNA5 of Q2 and Q3 was estimated to be 309 nt and 306 nt, respectively. Collectively the data confirmed that the faster migrating RNA species found in autonomously expressed RNAs of Q2 and Q3 is an authentic RNA5 comprised of fragments derived from Q2 and Q3 RNAs. Furthermore, failure to detect either subgenomic RNA4 (from genomic RNA3) or 4A (from RNA2), suggested that, in each case, RNA5 was produced independent of replication ( Fig. 1C) .
Deletion of Box1 blocks RNA5 production
Results summarized in Fig. 1C confirmed that production of RNA5 from transiently expressed Q2 and Q3 transcripts did not involve replication. Recent in vivo analysis revealed that deletion of Box1 region from CMV RNA3 had no detectable effect on replication and accumulation of progeny RNA3 and its subgenomic RNA4 (Thompson et al., 2008) . However, the effect of Box1 deletion on the replication and accumulation of RNA2 as well as its cumulative effect on overall accumulation of CMV progeny RNA is not known. To verify this possibility, we precisely deleted the sequence encompassing Box1 in all three Q-CMV genomic RNAs. (Fig. 1B) . Genomic Q1, Q2 and Q3 harboring the deletion of the Box1 will be referred to as Q1Δ, Q2Δ and Q3Δ respectively (Fig. 1B) . Agrotransformants of either Q1Δ or Q2Δ or Q3Δ (Fig. 1D) were autonomously infiltrated into N. benthamiana plants and the progeny was subjected to Northern blot hybridization. RNA5 production was completely blocked when the conserved Box1 was deleted either in Q2 (i.e. Q2Δ) or Q3 (i.e. Q3Δ) (Fig. 1C, lanes 6-7) , confirming the importance of the Box1 in RNA5 production.
To confirm the above observation in replication-dependent mode, an inoculum containing Q1Δ + Q2Δ + Q3Δ was infiltrated to N. benthamiana plants. Infiltration of an inoculum containing a mixture of all three wt Q-CMV genomic RNAs served as a positive control. Results of Northern blot hybridization are summarized in Fig. 1D . As expected, efficient accumulation of subgenomic RNAs 4 and 4A as well as RNA5 was detected in control plants (Fig. 1D, lane 1) . In contrast, leaves infiltrated with Q1Δ + Q2Δ + Q3Δ accumulated detectable levels of subgenomic RNAs 4 and 4A but not RNA5 (Fig. 1D, lane 2) . Results from Fig. 1 also support that the Box1 is not required for CMV genome replication and sgRNA4 production. Additionally, these results indicated that the conserved 20 nt sequence motif encompassing Box1 is required for RNA5 production (Thompson et al., 2008) .
Evidence that Q1 is competent to produce RNA5 RNA5 sequences accumulated in wt Q-CMV infections revealed that it is a heterogeneous mixture derived from Q2 and Q3 (Blanchard et al., 1996) . Our experiments involving autonomous expression of Q2 and Q3 confirmed these observations (Fig. 1C) . However, despite conservation of the Box1 in Q1, the reason for the lack of RNA5 production for Q1 is obscure. It is likely that abundant RNA5 produced from Q2 and Q3 could have masked RNA5 of Q1 even if it were produced at lower levels. Support for this conjecture was obtained when the RNA profile of Q1 + Q2Δ +Q3Δ was examined (Fig. 1D , lane 4). Although Q2Δ and Q3Δ were defective in RNA5 production due to the engineered deletion, a putative RNA5 accumulated to detectable Fig. 1 . Characteristics of the T-DNA plasmids used for agroinfiltration and their biological activity. (A) Plasmid constructs pCASS-Q1 (Q1), pCASS-Q2 (Q2), and pCASS-Q3 (Q3) contained full-length cDNA copies of wt Q-CMV genomic RNAs 1, 2 and 3, respectively. Similarly, plasmid constructs pCASS-F2 (F2) and pCASS-F3 (F3) contained full-length copies of Fny-CMV genomic RNAs 2 and 3, respectively. Single lines and open boxes represent non-coding and coding regions, respectively. The position of a single (for Q1) or double 35S promoter at the 5′ end and the positions of the ribozyme (Rz for Q2, F2, Q3 and F3) and the 35S terminator (Ter) at the 3′ end are shown. At the 5′^junction, the nucleotide sequence of the 35S promoter (lower case) and the 5′ sequence of each genomic cDNA (upper case) are shown. A bent arrow at the 5′ end indicates the expected transcription initiation site. At the 3′ end, viral (upper case) and non-viral (lower case) nt left after self-cleavage by the tobacco ring spot virus ribozyme are shown. A curved arrow shows the predicted self-cleavage site. A clover-leaf like structure at the 3′ end represents the tRNA-like structure (TLS). The sizes of the genomic RNAs and the number of non-viral nucleotides left after self-cleavage by the ribozyme (in parentheses) are indicated on the right. Note that for Q1 (and its derivatives) the absence of ribozyme at the 3′ end results in the addition of an unknown number (+N) of non-viral nucleotides. A black box in the 3′ non-coding region of each CMV genomic RNA represents the location of the Box1. (B) Characteristics of RNA5 defective variants. Mutants Q1Δ, Q2Δ and Q3Δ are characterized by deletion of a 20 nt sequence encompassing the conserved Box1 (shaded region in Q1, Q2 and Q3). A broken line represents the extent of the engineered deletion. The first and last nt positions for respective RNA5 lengths are shown in parentheses. (C) Autonomous transient expression of Q1Δ, Q2Δ and Q3Δ mutants. Nicotiana benthamiana leaves were infiltrated autonomously with indicated wt (lanes 2-4) or mutant Q-CMV genomic components (lanes 5-7). Lane 1 contained a mixture of all three Q-CMV RNAs. Total RNA was isolated from infiltrated leaves and subjected to Northern blot hybridization. Approximately 5 μg of total RNA isolated from agroinfiltrated leaves were denatured with formamide/formaldehyde, subjected to 1.2% agarose gel electrophoresis, transferred to a nylon membrane by vacuum blotting and hybridized with the Q300 probe. The positions of Q-CMV genomic (1, 2 and 3), subgenomic RNAs (4 and 4A) and RNA5 are shown. Ribosomal RNA (rRNA) is shown to indicate sample loadings. (D) Biological activity of Q-CMV genomic RNAs defective in RNA5 production. Agrotransformants of either Q1Δ or Q2Δ or Q3Δ mutants were co-expressed (lane 2) or each mutant genomic component was mixed with wt counterparts (lanes 4-^6) and infiltrated into N. benthamiana leaves. Control infiltrations contained wt Q-CMV (lane 1) or mock inoculated (M). Total RNAs were isolated and subjected to Northern blot hybridization as described above. The positions of Q-CMV genomic (1, 2 and 3), subgenomic (4 and 4A) and RNA5 are shown. Ribosomal RNA (rRNA) is shown to indicate sample loadings. (E) Evidence that Q1 is competent to produce RNA5. Leaves of N. benthamiana were infiltrated with a mixture containing agrotransformants of Q1, F2 and F3 (lanes 1 and 3) or all three wt Q-CMV genome components (lanes 2 and 4), total RNA was extracted, subjected to duplicate Northern blots and hybridized with either probe Q100 or probe Fny-CMV. The positions of Q-CMV genomic (1, 2 and 3), subgenomic RNAs (4 and 4A) and RNA5 are shown. Ribosomal RNA (rRNA) is shown to indicate sample loadings. levels in leaves infiltrated with Q1 + Q2Δ + Q3Δ (Fig. 1D) . It is possible that this putative RNA5 could have originated from the reconstituted Box1 in Q2 or Q3 due to recombination with the 3′ end of Q1. However sequencing analysis of progeny Q2Δ and Q3Δ confirmed that the engineered deletion was preserved (data not shown) suggesting that the putative RNA5 was derived from Q1. To further substantiate these observations, we performed the following experiment.
Unlike Q-CMV genomic RNAs (subgroup II), those of Fny-CMV (subgroup I) are inherently defective in RNA5 production and also lack the conserved Box1 region (Blanchard et al., 1997) . We exploited this inherent defect to examine whether Q1 is competent to produce RNA5 or not. Thus, N. benthamiana leaves were infiltrated with a recombinant inoculum containing Q1 + F2 + F3 and progeny RNA was subjected to Northern blot hybridization (Fig. 1E) . Results of these experiments suggested that RNA5 produced with Q1 + F2 + F3 (Fig. 1E , lane 1) must have been derived from Q1 since neither F2 nor F3 produce RNA5 (Fig. 1E, lane 3) . Additional sequence analysis of Q1 + F2 + F3 and Q1 + Q2Δ +Q3Δ progeny RNA by 5′RACE showed that the putative RNA5 present in these samples was indeed the authentic RNA5 derived from the 3′ UTR of RNA1 due to the presence of diagnostic bases that distinguish the 3′ end of RNA1 from that of RNAs 2 and 3 (Palukaitis and Garcia-Arenal, 2003) . Furthermore, sequence analysis also identified that, unlike RNA5 of Q2 and Q3 (Fig. 1B) , the first two nt of the Q1RNA5 are A and G residues ( Fig. 1B ) and are located 2 nt upstream of the Box1 analogous to Q2 and Q3. These results demonstrate, for the first time, that Q1 is competent to produce RNA5 but with lower efficiency than Q2 or Q3.
Sequence requirements for RNA5 production
Results presented above clearly demonstrated that production of RNA5 is independent of viral replication ( Fig. 1C ) and requires a 20 nt sequence encompassing the Box1 (Fig. 1B) . In addition, despite having a conserved Box1, the efficiency with which RNA5 is produced varied significantly among the three Q-CMV genomic RNAs (Fig. 1C) . The question that remains to be addressed is, what factors regulate this varied RNA5 production? Our sequence analysis of RNA5 showed that the first two nt upstream to the conserved Box1 are AG, UC and GC for Q1, Q2 and Q3, respectively (Fig. 1B) . Thus, we hypothesized that the efficiency of RNA5 is regulated by the first two nt 5′ to the conserved Box1. To substantiate this hypothesis, we created a set of six mutant sequences as follows: (i) wt Q1 AG was mutated to AC or UC; (ii) in wt Q2 UC was mutated to UG or AG and (iii) wt Q3 GC was mutated to GG or UC ( Fig. 2A) . To assess the effect of each of these engineered mutations on the production of the respective RNA5, each mutant genomic RNA was complemented with the remaining two genomic counterparts that are defective in RNA5 production (due to deletion of the Box1). A total of nine inocula were assembled. For example, for Q1, mutant Q1(AC) or mutant Q1(UC) was complemented with Q2Δ and Q3Δ. Co-expression of wt Q1 with Q2Δ and Q3Δ served as a positive control. In order to assess the efficiency of RNA5 production from the different RNAs, the Northern blot hybridization assay used a Q100 probe representing 100% of nucleotide identity with RNA1 and RNA3 sequences, and 99% identity with RNA2 sequence. Thus, the hybridization intensity should correlate with the amount of RNA5 produced irrespective of the source of genomic RNA.
The penultimate 5′ nt for Q2 and Q3 is a C residue while Q1 has a G residue. Since both Q2 and Q3 produce detectable levels of RNA5, we envisioned that Q1(AC) would produce detectable levels of RNA5. Indeed compared to Q1 (Fig. 2B , lane 1), mutant Q1(AC) resulted in detectable levels of RNA5 (Fig. 2B, lane 2) . The importance of the C residue at the penultimate position was further accentuated by an observed decrease in RNA5 production for mutant Q2 and Q3. For example, when the penultimate C residue in Q2 and Q3 was substituted with a G residue, the production of RNA5 for Q2(UG) was reduced by 40% (Fig. 2B , lane 5) whereas that of Q3(GG) was reduced beyond detectable levels (Fig. 2B , lane 8). Since Q2 is the most efficient producer of RNA5 followed by Q3, with Q1 producing the least (Fig. 2B) , we reasoned that UC was the most preferred 5′ nucleotide pair over AG (for Q1) or GC (for Q3). To substantiate this hypothesis, the 5′ AG of Q1 and GC of Q3 was substituted with UC in each case. As a control the 5′ nucleotide pair UC in Q2 was substituted with AG. As expected, having UC as a 5′ nt pair for Q1(UC) and Q3(UC) resulted in a substantial increase in RNA5 production approaching nearly 500% (Fig. 2B , lane 3) and 600% (Fig. 2B , line 9) respectively when compared to corresponding Q1 and Q3. In the control sample, when UC was substituted with AG in Q2(AG), the production of RNA5 was reduced by 80% (Fig. 2B , lane 6). Collectively these results indicate that UC is the preferred 5′ nt pair for high level production of RNA5 and provides a valid explanation for reduced levels of RNA5 in Q3 and Q1.
When sequences encompassing the RNA5-box of Q1, Q2 and Q3 were analyzed through M-fold software for secondary structure (Mathews et al., 1999) , it predicted the presence of identical stemloop structures (Fig. 2C) . A recent biochemical study confirmed the existence of similar secondary structural elements in RNA3 of subgroup II R-CMV (Thompson et al., 2008) . Interestingly, the 5′ nt pair upstream to the RNA5-box was more or less part of the predicted stem-loops. In Q1 the 5′ nt pair AG resulted in a shorter stem compared to that of Q2 or Q3. The relative efficiency of RNA5 production in Q1, Q2 and Q3 could be attributed to the stability of stem-loop structure offered by variation in the 5′ nt pair.
In the RNA silencing pathway, RISC (Eamens et al., 2008 ) is responsible for cleaving the target mRNA leading to accumulation of 5′ and 3′ degradation fragments (Li and Ding, 2006) . These fragments are either accumulated or subjected to further degradation by exonuclease or DICER activity (Li and Ding, 2006) . Therefore RNA5 could have accumulated as a stable degradation product following RISC cleavage of Q-CMV genomic RNAs. The PIWI domain of Argonaute protein carries out the ribonuclease activity of the RISC complex (Rivas et al., 2005) . Six of the ten Ago proteins, Ago1, Ago2, Ago3, Ago5, Ago7 and Ago10, are known to have intact PIWI domains responsible for cleavage (Baumberger and Baulcombe, 2005) . Whether RNA5 is produced through the Ago ribonuclease activity or not was tested by inoculating Q-CMV to Arabidopsis thaliana plants having a mutation in one of above-mentioned six Ago proteins. Northern blot analysis of total RNA recovered from A. thaliana mutant plants revealed that RNA5 accumulation was not affected (data not shown). Therefore we conclude that Ago proteins are not involved in RNA5 production. As long as Ago proteins might have redundant activities, we also tested RNA5 production in triple mutants Ago1/5/10 and Ago1/7/10, and unable to visualize any decrease in RNA5 production.
What role does RNA5 play in Q-CMV life-cycle?
The significance of RNA5 in the CMV life cycle is not known. A role for RNA5 in symptom attenuation (Shi et al., 2008) , as well as in virus assembly and/or replication (Blanchard et al., 1996; Gould et al., 1978) was proposed. No such evidence was found in this study since symptom and encapsidation phenotypes associated with an inoculum containing Q1Δ + Q2Δ + Q3Δ (completely defective in RNA5 production) were indistinguishable from those of wild type (data not shown). However, quantitative analysis of progeny accumulation revealed that Q1Δ +Q2Δ + Q3Δ progeny accumulated approximately 25% lower than that of wt (Fig. 1D) . The reason for this reduction in accumulation is unknown. Interestingly, over accumulation of shorter RNAs produced during replication of tomato bushy stunt virus (TBSV) due to the absence of host exoribonuclease Xrn1 promoted recombination (Cheng et al., 2006) . Cucumoviral RNA5 has been often envisioned to play a major role in recombination (de Wispelaere et al., 2005) . Consequently to test the extent to which RNA5 contributes to recombination, the following experimental system was designed and tested in planta.
Experimental system designed to assess the role of RNA5 in recombination
The 3′TLS of CMV and BMV contain a highly conserved stem-loop C (SLC) and terminates with the sequence CCA OH (Sivakumaran et al., 2000) . In vitro studies showed that CMV replicase was able to recognize promoter elements of BMV TLS and initiate minus-strand synthesis (Sivakumaran et al., 2000) . Furthermore, a BMV RNA3 chimera terminating with Fny-CMV TLS replicated in planta when complemented with BMV replicase (Rao and Grantham, 1994) . However, this chimera was rapidly repaired through recombination with the 3′ ends of BMV RNAs 1 and/or 2, restoring a functional BMV RNA3 (Rao and Grantham, 1994) . Based on these observations, in this study, we developed an experimental system by constructing two variants of Q3. The first variant, a chimera referred to as Q3B3 (Fig. 3A) , was constructed by replacing the 3′TLS of Q-CMV RNA3 (nt 2065-2197) with that of BMV RNA3 (nt 1954-2111) . A second variant was a derivative of Q3B3, referred to as Q3ΔB3 (Fig. 3A) , in which the highly conserved Box1 was deleted. Consequently this variant will be defective in RNA5 production.
We assembled four different inocula (Fig. 3B ). These are referred to as I, II, III and IV and are respectively composed of Q1Δ + Q2Δ +Q3ΔB3, Q1Δ + Q2Δ + Q3B3, Q1 + Q2 + Q3ΔB3 and Q1 + Q2 + Q3B3. Two additional inocula were assembled to serve as controls. These are referred to as Q (i.e. Q1 + Q2 + Q3 that is competent to produce RNA5) and QΔ5 (Q1Δ + Q2Δ + Q3Δ that is defective in RNA5 production) (Fig. 3B) . In inocula III (Q1 + Q2 + Q3ΔB3) and IV (Q1 + Q2 + Q3B3), Q5 is expressed from RNA1 and RNA2, and could serve as a template for recombination-mediated repair of the Q3B3 TLS. Comparison between inocula I/ II and III/IV would allow us to assess the importance of RNA5 acting as a donor strand in RNA-RNA recombination. Furthermore, the comparison between inocula I/III, that contained Q3ΔB3, and inocula II/IV, that contained Q3B3, would elucidate whether or not RNA5 production from the acceptor strand facilitated recombination. Six days post-infiltration of N. benthamiana with each inoculum, total RNAs were extracted and the viral progeny was analyzed by Northern blot hybridization (Fig. 3C ) and RT-PCR (Fig. 3D) .
The emergence of recombinant molecules between chimeric RNAs 3 and other viral RNA carrying the Q-CMV TLS can be easily monitored by Northern blot hybridization using specific probes (Fig. 3E) . These are (i) a probe referred to as Q100 hybridizing within the Q-CMV TLS (nt 2104-2197 of Q-CMV RNA3) which would specifically detect Q-CMV RNAs 1, 2, 4A and 5, as well as RNA3 recombinants carrying the Q-CMV TLS; (ii) another probe referred to as the BMV probe, complementary to the BMV 3′-non-coding region (nt 1911-2111) (Rao and Grantham, 1994) , that would allow us to detect Q3B3 and Q3ΔB3, as well as their progeny RNA4 (referred to as Q4B4) and the chimeric RNA5 of Q3B3 (referred to as Q5B5); and finally (iii) a probe referred to as Q300, complementary to the entire Q-CMV 3′-non-coding region (nt 2729-3035 of Q-CMV RNA2), that would detect all of the expressed RNAs, as well as the recombinants.
Three identical Northern blots were generated and hybridized independently with each probe (Fig. 3C) . Two control inocula, Q and QΔ5, resulted in the expected progeny RNA profile i.e. presence and absence of RNA5 respectively for Q and QΔ5 (Fig. 3C , panels Q100 and Q300). Failure to detect any progeny RNA in these two inocula by the BMV probe exemplifies the specificity of this probe (Fig. 3C, panel  BMV) . In each of the four inocula, progeny of Q3B3 and Q3ΔB3 chimera accumulated and replicated to high levels, as evidenced by the production of Q4B4 (Fig. 3C, panel BMV) . This also suggested that the overall level of replication for each inoculum was comparable to those of wild type (Fig. 3C, panel Q300 ). As expected, Q5 was found to accumulate only for inocula III and IV (Fig. 3C, panel Q100 ) and Q5B5 for inocula II and IV (Fig. 3C, panel BMV) .
Northern blots hybridized with all three probes also identified two putative recombination products, referred to as α and β, carrying a 3′ TLS from Q-CMV (Fig. 3C ). However these two recombinant products accumulated to very low levels perhaps due to their inability to compete for replication with abundant chimeric RNA3. As a consequence, they were lost in systemic leaves of primary infected plants and were also unable to sustain reinoculation onto a second set of plants (data not shown). It was shown previously that when RNA3 of TAV was replicated by CMV replicase, a recombinant RNA3 carrying the CMV 3′-non-coding region arose rapidly and was selected over the wild type TAV RNA3 (Fernandez-Cuartero et al., 1994; Shi et al., 2008; Suzuki et al., 2003) . In light of these observations, we envisioned that CMV replicase would preferentially amplify molecules carrying the Q-CMV TLS i.e. recombinant molecules detected in this study (Fig. 3C) . But it was not the case. Instead, CMV replicase maintained chimeric Q3 with a BMV 3′ TLS.
As revealed by hybridization with the Q100 probe (Fig. 3C) , two types of recombination products were generated in different sets of inoculated leaves, although they accumulated to low levels. The first type of recombinant migrated at the same position as Q3 and was present in all four inocula (α in Fig. 3C , panel Q100). It is likely that a recombination event replaced the BMV TLS of the chimera with that of Q-CMV. The second type of recombinant molecule migrated slower than Q3 and was only present in leaf samples infiltrated with inocula III and IV (β in Fig. 3C ). This slower migrating molecule could be detected by hybridization with both BMV and Q-CMV probes, revealing its chimeric nature (see below).
In order to analyze the sequences of recombinants α and β and their crossover junctions, we performed RT-PCR on each sample. We used a set of primers that specifically amplify only Q-CMV RNA3. The region amplified by these primers included the entire 3′ non-coding region and a part of the CP ORF. As a positive control for RT-PCR, sample Q (i.e. wt Q-CMV) was used. Amplification of the positive control resulted in the detection of the expected 698 bp product (Fig.  3D) . The same set of primers, however, failed to amplify a RT-PCR product from the negative control (a mixture of Q1, Q2, Q3B3 and Q5 RNAs; see Material and methods), showing neither a non-specific amplification of Q3B3 nor in vitro recombination had occurred during RT-PCR (Fig. 3D) . However a RT-PCR product comparable in size with that of the positive control (i.e. 698 nt) was detected for RNA samples of inocula I and II. On the other hand, RNA samples from inocula III and IV yielded two different RT-PCR products: one product of 698 nt, similar in size to the positive control and a second product of 1 kb. These RT-PCR products are likely to represent the recombinant molecules α and β, that have been detected by Northern blot hybridization (Fig. 3C) . Each of these RT-PCR products was cloned into a pGEM-T easy vector and several clones were subjected to sequencing. The sequencing data revealed that these molecules are the result of recombination events between Q3B3 RNA and the 3′ noncoding regions of RNA1 or RNA2.
Characterization of precise homologous recombinants
Nucleotide sequence of the α recombinants found in each inoculum was first analyzed. The number of clones analyzed for inocula I, II, III and IV was respectively 9, 8, 6 and 8. In all cases, we found that the recombination was precise, i.e. the crossover occurred within the 3′ non-coding region, upstream to the TLS and at 5 different regions of identity existing between the parental RNAs (regions a to e in Fig. 4A ). Following Lai's classification, we referred to these molecules as homologous precise recombinants (Jarvis and Kirkegaard, 1991; Lai, 1992; Nagy and Simon, 1997) . No recombination occurred within the TLS or the ORF sequences, as these regions did not present any sequence identity between Q1/Q2 and Q3B3 (Fig. 4B) . Further data analysis showed that recombination events occurred between Q3B3 and Q1 as well as Q2 derived sequences. As expected, recombination was highly dependent on sequence identity and for the majority of the clones (17 out of 31) recombination had occurred within region c, encompassing a block of 41 nt conserved in all Q-CMV RNAs. For inocula I, II and III, most recombinants were clustered within region c (respectively 5/9, 7/8 and 3/6), whereas in inoculum IV only 2 out of 8 clones had their crossover site within region c. In inoculum IV, a majority of the clones (5/8) clustered within region a, that presented only 21 nt of sequence identity. Region a contained the 20 nt Box1 sequence, an important element required for RNA5 production (Fig. 1D) . Because Box1 was deleted from either one (inocula II and III) or both (inoculum I) genomic RNAs, recombination within this conserved region could occur only in inoculum IV (Fig. 4B) .
Characterization of non-homologous recombinants
The 1 kb PCR products corresponding to recombinant β amplified from inocula III and IV (Fig. 3D ) were cloned and 14 independent clones were sequenced in each case. For all molecules, the recombination did not occur between similar regions of the genome and therefore led to duplication within the 3′ non-coding region (Fig. 5A) , resulting in β recombinants of larger size than the α recombinants described above. This characteristic feature led us to classify these molecules as non-homologous recombinants (Jarvis and Kirkegaard, 1991; Lai, 1992; Nagy and Simon, 1997) . Sequence analysis indicated that these non-homologous recombinants were generated by addition of the entire Q-CMV RNA5 sequence at the 3′ terminal end of the chimeric RNA3 (Fig. 4A) . In all cases, the first nucleotide incorporated at the junction was the first nucleotide of RNA5 (A for RNA1 derived RNA5; U for RNA2 derived RNA5; see Fig. 1B) .
Interestingly, the 17 extra nts that remained at the 3′ end of the chimeric RNA3 following ribozyme cleavage were conserved at the junction between Q3ΔB3 or Q3B3 and RNA5 (Fig. 5B) . This result was unexpected since in CMV initiation of negative strand synthesis by viral replicase occurs at the penultimate C residue of the 3′ CCA OH terminus (Sivakumaran et al., 2000) . Consequently after a first round of replication, the 3′ extra nucleotides should be lost in favor of the native CCA OH 3′ end (Annamalai and Rao, 2005; Burgyan and GarciaArenal, 1998) . Therefore this recombinant must have been generated using input RNA3 as a template.
The nucleotide divergence existing between Q-CMV RNA1 and RNA2 allowed us to precisely identify the origin of the RNA5 incorporated into the recombinant molecules. In both inocula III and IV, only 2 out of 14 clones had incorporated RNA1 derived RNA5, whereas the majority of clones (12 out of 14) carried the RNA2 derived RNA5 sequence (Fig. 5B) .
Discussion
Production of RNA5 is replication independent
Comparison of sequences encompassing the Box1 to those of known subgenomic RNA promoters of several positive strand RNA viruses did not reveal any homology to suggest that production of RNA5 is mediated via subgenomic RNA synthesis (Blanchard et al., 1996) . Interestingly, a striking homology observed between a putative subgenomic RNA promoter of RNA3sub of BNYVV and the Box1 prompted previous investigators to surmise that production of Q-CMV and V-TAV RNA5 was derived via a subgenomic RNA mechanism (Blanchard et al., 1997; Shi et al., 1997) . However, recent experimental evidence revealed that the RNA3sub of BNYVV is not produced as a subgenomic RNA (D. Gilmer, personal communication). Furthermore, unlike all known capped subgenomic RNAs associated with member viruses of the Bromoviridae family, RNA5 of Q-CMV RNA5 is not capped. Therefore it could not have been produced as a subgenomic RNA and may have arisen due to specific ribonuclease activity (Blanchard et al., 1996) . Results of this study clearly established that RNA5 of Q-CMV is not produced through a subgenomic RNA mechanism since autonomous expression of Q-CMV genomic RNAs (Eamens et al., 2008) are competent to produce detectable amounts of RNA5. This observation suggests that RNA5 could be a product of host ribonuclease activity. Our initial experiments failed to link RNA5 production to Ago ribonuclease activity. However in TBSV, over expression of yeast Ngl2p endoribonuclease led to an increased accumulation of shortened RNAs (Cheng et al., 2006) . Similarly a recent study involving bipartite red clover necrotic mosaic virus (RCNMV) showed an encapsidation competent 3′ non-coding 400 nt fragment (SR1f) was efficiently generated from RNA1. SRf1 is generated as stable degradation product by a 58 nt sequencemediated (SRf158) protection against 5′→3′ RNA decay (Iwakawa et al., 2008) . Therefore it is likely that Box 1 might function analogous to that of SRf158 in producing and protecting RNA5. In light of these findings the involvement of other host ribonucleases in RNA5 production remains to be tested.
Q-CMV genomic RNAs produce RNA5 with different efficiencies
Initial sequence analysis of RNA5 of Q-CMV RNAs 2 and 3 (Blanchard et al., 1996) showed that the first nucleotide in each case was a G residue which was also the first nucleotide of the Box1 (Fig.   1B) . Shi et al. (1997) identified that the first nt of the RNA5 of V-TAV RNA3 was located two nt upstream of the Box1. Reanalysis of RNA5 of Q-CMV and V-TAV RNAs by Blanchard et al. (1997) revealed that the first nt of each respective RNA5 was different from the previously published data. Our 5′RACE analysis of RNA5 of Q-CMV RNAs 1, 2 and 3 identified that, like that of V-TAV (Shi et al., 1997) , in each case, the first nt of RNA5 is located 2 nt upstream of the Box1 (Fig. 1B) . A likely reason for the observed variation in identifying the 5′ proximal nt could be attributed to different techniques applied in identifying the first nt of RNA5 (primer extension vs 5′RACE).
Our study has convincingly showed that Q1 is competent to produce RNA5 (Fig. 1E) . In addition we also showed that Q1, Q2 and Q3 produce their respective RNA5 at different levels, Q2 being most efficient followed by Q3 and Q1 (Fig. 1C) . A characteristic difference between each genomic RNA in producing varying levels of RNA5 is the 5′ proximal nt pair upstream to the conserved Box1 i.e. AG for Q1, UC for Q2 and GC for Q3. Our initial mutations in delineating sequences regulating RNA5 production identified that efficient production occurs with UC being the most preferred nt pair (Fig. 2B) . However for Q1, compared to AG (wt), UC resulted in increased production of RNA5 but never approached that of either Q2 (wt) or Q3 (UC). Furthermore the 5′ nt pair has an impact on the stability of the stem-loop structures (Fig. 2C ) that are likely to influence RNA5 production. Recently it was shown that integrity of the stem-loop structure was crucial for RNA5 production (Thompson et al., 2008) . Additional mutational analysis of other sequences surrounding the Box1 is required to further address this issue. In addition, the 5′ nt pair might have other roles such as replication of RNA5 by host RdRp or Q-CMV replicase. Whether RNA5 is replicated using either of these enzymes remains to be determined but the fact that RNA5 has been directly or indirectly implicated in recombination (de Wispelaere et al., 2005; Shi et al., 2008; Suzuki et al., 2003) favors the idea that it is recognized by CMV replicase.
Role of RNA5 in recombination
Results of our experiments using inocula I, II and III shown in Fig.  4B revealed that the generation of precise homologous recombinants was strongly dependent on sequence identity. Accordingly, in inocula I, II and III, most recombination occurred within region c, which was the largest block of identity available. However, in inoculum IV, when Box1 was present on both parental RNAs, the recombination was shifted from region c to the Box1 (region a). A similar observation was also reported in another study involving CMV and TAV RNAs 3, where recombination occurred mostly at the site of the Box1, even though this was not the highest block of identity between the parental RNAs (de Wispelaere et al., 2005; Fernandez-Cuartero et al., 1994; Masuta et al., 1998; Shi et al., 2008; Suzuki et al., 2003) . This finding suggested that the presence of Box1 sequences in acceptor and donor strands had a strong influence on the production of precise homologous recombinant molecules at the site of the Box1. We hypothesized that observed recombination can be classified into Class1 recombination of Nagy and Simon (1997) and that RNA5 was the donor template for recombination rather than RNA1 or RNA2 (Fig. 4C) due to the For each region (a to e), recombination could occur between RNA1 and RNA3 or between RNA2 and RNA3. When recombination occurred between RNA1 and RNA3, the recombinant is noted as Q3-^Q1. When recombination occurred between RNA2 and RNA3, the recombinant is noted as Q3-Q2. The number of clones found for each type of recombinant is indicated relative to the total number of clones sequenced for each inoculum. When no recombination could occur, it is represented as not applicable (n.a). When no recombinant was found it is represented as a minus sign. On the left side of panel, the four different inocula used are schematically shown. The open boxes represent the 3′ ends of the RNAs ORF. Black boxes represent the Box1. The genomic RNAs competent to produce RNA5 are represented by a bent arrow. Broken lines represent the BMV TLS sequence located after position 2064 in Q-CMV RNA3. In a given inoculum, regions involved in recombination are shown between vertical broken lines, and the template switches involved therein are represented by a two sided arrow. (C) Schematic model involving RNA5 in promoting homologous precise recombination. In this model, first the CMV replicase (represented by a grey circle) binds to RNA5 of Q1 or Q2 (step 1) and synthesizes a complementary minus strand (step 2). In step 3, while the replicase remains attached to the newly synthesized (−) RNA5 strand, template switching results in reinitiation of synthesis on Q3B3 (step 3) followed by the release of the recombinant (−) RNA (step 4) which ultimately will be copied into a recombinant (+) strand. The sequence complementarity provided by the Box1 (indicated by +++ in step 3) promotes precise homologous recombination. following three reasons: (i) our data showed that RNA5 is not produced through replication (Fig. 1C) . Therefore it is unlikely for Box1 to act as a recognition element for the CMV replicase after the template switch, and it is unlikely that recombination belonged to Class2 or Class3 of Nagy and Simon (1997) ; (ii) as mentioned earlier Box1 does not exhibit the largest region of identity compared to region c between acceptor and donor strands. However, presence of Box 1 in acceptor and donor strands favored a recombinational switch over region c. Therefore, RNA feature rather than sequence identity has to favor the recombination within Box1. Most likely, the donor strand was RNA5 and the natural 5′-end of RNA5 induced termination of synthesis and template switch; (iii) In agreement with this hypothesis, we observed that for recombination to occur within Box1 all donor strands are originated from RNA2 and none from RNA1 (region a in Figs. 4A and B) . Since majority of RNA5 molecules are derived from RNA2, this confirmed that RNA5, not RNA2 per se, is the preferred template for recombination. This also implied that recombination occurred during minus strand synthesis and that CMV replicase could initiate minus-strand synthesis on RNA5 before switching templates, as schematically shown in Fig. 4C .
Studies leading to the characterization of cucumoviral nonhomologous recombinants identified that crossovers occurred within the stem-loop of the TLS located~150 nt upstream of the 3′ end (nt 2045-2064 in Q-CMV RNA3 referred to as B3 arm) (Masuta et al., 1998; Shi et al., 2008; Suzuki et al., 2003) . It is noteworthy that in our case the junctions with RNA5 did not involve the RNA3 TLS B3 arm, even (1)) and Q3ΔB3 or Q3B3 respectively resulted in the emergence of recombinants Q3ΔB3Q5(1) and Q3B3Q5(1). Recombination between Q2 derived RNA5 (Q5(2)) and Q3ΔB3 or Q3B3 respectively resulted in the emergence of recombinants Q3ΔB3Q5 and Q3B3Q5. (B) Recombinants obtained with four sets of inocula used in this study. The sequences at the junction of recombinants Q3ΔB3Q5(1) and Q3B3Q5(1) (top sequence) and Q3ΔB3Q5 and Q3B3Q5 (bottom sequence) are shown. The 3′ end of Q3B3 or Q3ΔB3 is shown in grey. The 22 nts left after self-cleavage by ribozyme are shown in italics. The first two nucleotides of RNA5 are boldfaced and underlined. Sequence encompassing the Box1 is shown in bold. The nt positions of BMV RNA3, Q-CMV RNAs 1 and 2 within the recombinant sequences are indicated. The distribution of recombinants for inocula III or IV is shown by the number of clones obtained relative to the total number of clones sequenced. (C) Schematic model for the generation of non-homologous recombinants. Following recognition of Q5 by the CMV replicase (indicated by grey circle), minus strand RNA5 is synthesized (step 1). While the replicase remains attached to the newly synthesized strand, it switches template (step 2) and reinitiates synthesis by recognizing the minus strand promoter of Q3B3 (step 3), which ultimately led to the synthesis and release of the non-homologous recombinant (step 4).
though this Q-CMV sequence was preserved in the chimera. Recombinants with duplication of an RNA5 at the terminal 3′ end of the acceptor RNA were only seen in the case of ALS-CMV, where some crossovers occurred 15 nt upstream of the terminal CCA OH (Chen et al., 2002) . However this type of end-to-end template switching was described for bovine viral diarrhea virus (Lai et al., 1999) , as well as for viruses within the Tombusviridae family (Cheng and Nagy, 2003) . CMV replicase was also shown to be able to perform end-to-end template switching in vitro (Kim and Kao, 2001) .
Results of this study show that the production of non-homologous recombinant molecules is dependant on the presence of Box1 and RNA5 production. When both RNAs 1 and 2 are competent to produce RNA5, the RNA5 sequence present in recombinant molecules predominantly originated from RNA2. This correlated with our observation that RNA2 produces a higher amount of RNA5 compared to RNA1 (Fig. 1C) . We also observed that RNA5 production from the acceptor strand had no effect on the appearance of the recombinants (Q3B3 versus Q3ΔB3 in Fig. 3C ). This result clearly Table 1 Primers used for constructing wild type and mutant CMV agro-plasmids
Plasmid
Primer# Oligonucleotide sequence (5′→3′) Comments pCASS-Q2 1 GTTTATTCTCAAGAGCGTATGGT To subclone full-length Q2 cDNA into pCASS-Rz. A PCR product was amplified using primers #1 and #2 (BamHI site is underlined), digested with BamHI and subcloned into StuI/BamHI treated pCASS-Rz.
2 A C GGATCCTGGTCTCCTTATGGAGAA pCASS-Q3 3 GTAATCTTACCACTTTCTTTCACG To subclone full-length Q3 cDNA into pCASS-Rz essentially as described above using primers #3 and #4 (BamHI site is underlined). 4
A C GGATCCTGGTCTCCTTATGGAGAA pCASS-F2 5 GTTTATTTACAAGAGCGTACGG To subclone full-length F2 cDNAinto pCASS-Rz essentially as described above using primers #5 and #6 (BamHI site is underlined). 6
A C GGATCCTGGTCTCCTTTTGGAGGCCCCAC pCASS-F3 7 GTAATCTTACCACTGTGTGTGTGCGT To subclone full-length F3 cDNA into pCASS-Rz essentially as described above using primers #7 and #8 (BamHI site is underlined). 8
A C GGATCCTGGTCTCCTTTTGGAGGCCCCCA pCASS-Q1Δ 9 AGAGCGACCGCTATGCTTGA To construct Q1 defective in RNA5 production by deleting 20 nt sequence encompassing RNA5-box. Two PCR products were amplified using primers 9 and 10 and primers 11 and 12 (BamHI site is underlined). These two PCR products were fused using primers 9 and 12, digested with BstEII and subcloned into BstEII/SmaI treated pCASS-Q1.
10 TCGCAATAAAGAGAGCCTTCCGCGATCAGACT 11 AGTCTGATCGCGGAAGGCTCTCTTTATTGCGA 12 ACGGATCCTGGTCTCCTTATGGAGAACCT pCASS-Q2Δ 13 TCTAAGCTCCCACCTGTT To construct Q2 defective in RNA5 production by deleting a 20 nt sequence encompassing RNA5-box. Two PCR products were amplified using primers #13 and #14 and primers #15 and #16 (BamHI site is underlined). These two PCR products were fused using primers #13 and #16, digested with MfeI and BamHI and subcloned into a similarly treated pCASS-Q2.
14 TCGCAATAAAGAGAGCGACGAAGGGTCGGA 15 TCCGACCCTTCGTCGCTCTCTTTATTGCGA 16 ACGGATCCTGGTCTCCTTATGGAGAACCT pCASSQ3Δ 17 TTGGTTACGGTGGTACCACTGCTAGCGT To construct Q3 defective in RNA5 production by deleting a 20 nt sequence encompassing RNA5-box. A PCR product amplified using primers #17 and #18 was digested with XbaI and NruI and subcloned into a similarly treated pQCD3 (11). A PCR product was amplified on pQCD3Δ using primers #3 and #4, digested with BamHI and subcloned into StuI/BamHI treated pCASS-Rz.
18 CGATTGAGAGTGCCGGTAAACACACGG pCASS-Q1(AC) 19 AGAGCGACCGCTATGCTTGA To mutate the penultimate 5′ guanine residue of RNA5 of Q1 to cytosine. Two PCR products were amplified using primers #19 and #20 and primers #21 and #22 (BamHI site is underlined). The two PCR products were fused using primers 19 and 22, digested with BstEII and subcloned into BstEII/SmaI treated pCASS-Q1. TCTTCGGACGTTCCGCGATCAGACTAACGGA  21  TCCGTTAGTCTGATCGCGGAACGTCCGAAGA  22 ACGGATCCTGGTCTCCTTATGGAGAACCT pCASS-Q1(UC) 23 AGAGCGACCGCTATGCTTGA To mutate 5′ proximal AC→UC in RNA5 of Q1. Two PCR products were amplified using primers #23 and #24 and primers #25 and #26 (BamHI site is underlined). The two PCR products were fused using primers 23 and 26, digested with BstEII and subcloned into a BstEII/SmaI treated pCASS-Q1.
20
24
ATTCGTCTTCGGACGATCCGCGATCAGACT 25 AGTCTGATCGCGGATCGTCCGAAGACGTTA 26 ACGGATCCTGGTCTCCTTATGGAGAACCT pCASS-Q2(UG) 27 TCTAAGCTCCCACCTGTT To mutate the penultimate 5′ cytosine to guanine residue in RNA5 of Q2. Two PCR products were amplified with primers #27 and #28 and primers #29 and #30 (BamHI site is underlined). The two PCR products were fused using primers #27 and #30, digested with MfeI and BamHI and subcloned into a similarly treated pCASS-Q2. 29  TCCGACCCTTCGTGGTCCGA  30 ACGGATCCTGGTCTCCTTATGGAGAACCT pCASS-Q2(AG) 31 TCTAAGCTCCCACCTGTT To mutate 5′ proximal UC→AG in RNA5 of Q2. Two PCR products were amplified using primers #31 and #32 and primers #33 and #34 (BamHI site is underlined). The two PCR products were fused using primers #31 and #34, digested with MfeI and BamHI and subcloned into a similarly treated pCASS-Q2. 32 TAACGTCTTCGGACCTCGAAGGGTCGGA 33 TCCGACCCTTCGAGGTCCGAAGACGTTA 34 ACGGATCCTGGTCTCCTTATGGAGAACCT pCASS-Q3(GG) 35 TTGGTTACGGTGGTACCACTGCTAGCGT To mutate the penultimate 5′ cytosine to guanine residue in RNA5 of Q3. A PCR product was amplified with primers #35 and #36 using pQCD3 as a template (11), digested with XbaI and NruI and subcloned into a similarly treated pQCD3 resulting in pQCD3(GG). Finally, the full-length Q3 was amplified from pQCD3(GG) using primers #3 and #4 and subcloned into StuI/BamHI treated pCASS-Rz.
GTTTAACGTCTTCGGACCACGAAGGGT
CGATTGAGAGTGTAGTTTAACGTCTTCGGACCCCGGTAAACACACGG
pCASS-Q3(UC) 37 TTGGTTACGGTGGTACCACTGCTAGCGT To mutate the 5′ proximal guanine to uracil residue in RNA5 of Q3. A PCR product was amplified with primers #37 and #38 using pQCD3 as a template (11), digested with XbaI and NruI and subcloned into a similarly treated pQCD3, resulting in pQCD3(UC). Finally, the full-length Q3 was amplified from pQCD3(UC) using primers #3 and #4 and subcloned into StuI/BamHI treated pCASS-Rz. showed that RNA5 plays a major role in non-homologous recombination. As schematically shown in Fig. 5C , we hypothesized that, as observed in precise recombination, RNA5 was primarily recognized by the replicase and copied into a minus strand. After termination of synthesis due to the natural 5′-end of RNA5, the replicase would recognize the minus strand promoter located at the 3′ end of RNA3, according to the Class2 similarity non-essential mechanism of recombination (Nagy and Simon, 1997) . After resuming RNA synthesis, the replicase would ultimately release the non-homologous recombinant RNA (Fig. 5C ). Mechanistic hypotheses that we offered here (Figs. 4C and 5C) imply that recombination had occurred during minus strand synthesis of RNA5 by CMV replicase. It is known that RNA5 is primarily produced as a positive strand RNA independent of replication ( Fig. 1C) through an unknown mechanism. Currently there is no evidence for RNA5 being copied into minus strands either by viral or host RNA polymerase. In addition to recombination, RNA5 might contribute to translation. For example, as we demonstrated for CMV RNA5 in this study, SR1f of RCNMV was not produced as a subgenomic RNA but was generated as a stable degradation product of a 58 nt cis-acting RNA element-mediated protection against 5′→3′ decay (Iwakawa et al., 2008) . Furthermore it was demonstrated that SR1f trans inhibits both cap/poly(A)-dependent and 3′TE-DR1-mediated cap-independent translation in vivo and in vitro, resulting in a decrease in negative-strand RNA synthesis of RCNMV genomic RNAs (Iwakawa et al., 2008) . Agroinfiltration experiments involving the transient expression of RNA5 to evaluate its functionality as active templates in promoting recombination and in regulating translation are in progress.
Materials and methods
Construction of wt and mutant CMV plasmids for agroinfiltration
Procedures used to subclone full-length cDNA clones of Q-CMV or Fny-CMV genomic RNAs into a binary vector (pCASS4 or pCASS-Rz) amenable for agroinfiltration were described previously (Annamalai and Rao, 2005) . T-DNA plasmid for Q1 (pCASS-Q1; Fig. 1A ) was kindly provided by Dr. Shou-Wei Ding. Full-length cDNA clones of Q2 and Q3 were amplified by PCR using appropriate forward and reverse primers ( Table 1) . The resulting PCR products were digested with BamHI and subcloned into StuI-BamHI digested pCASS-Rz.
To construct plasmids Q1Δ, Q2Δ and Q3Δ (Fig. 1B) defective in producing RNA5, a highly conserved 5′ 20 nt region (referred to as the Box1) was deleted using PCR (Table 1) . A nucleotide pair AG, UC and GC, respectively in Q1, Q2 and Q3 located 5′ of the Box1 was mutated in corresponding cDNA clones using PCR (Table 1 ). The resulting plasmids were designated as pCASS-Q1(AC), pCASS-Q1(UC), pCASS-Q2(UG), pCASS-Q2(AG), pCASS-Q3(GG) and pCASS-Q3(UC).
To construct pCASS.Rz-Q3B3, initially two independent PCR products were amplified. The first product was amplified from Q3 cDNA using primers #44 and #45 (Table 1 ). The second product was amplified from B3 (BMV RNA3) cDNA using primers #46 and #47 (Table 1) . A third round of PCR, using these two fragments as templates, was performed with primers #44 and #47. The final fusion product was double digested with NruI and BamHI and subcloned into similarly treated pCASS.Rz-Q3. To construct pCASS.Rz-Q3ΔB3, the NcoI-NruI fragment was excised from pCASS.Rz-Q3Δ and subcloned into a similarly treated pCASS.Rz-Q3B3.
Agroinfiltration and progeny analysis
Procedures used to grow Agrobacterium cultures followed by infiltration of N. benthamiana leaves were as described previously (Annamalai and Rao, 2005; Annamalai and Rao, 2006) . Extraction of total RNA from agroinfiltrated leaves and their analyses by Northern hybridization was as described previously (de Wispelaere et al., 2005) . Depending on the contents of the Northern blot, one of the following four 32 P-labeled DNA probes was used: (i) Q100, representing to the Q3 3′ 95 nt sequence, was amplified by PCR using primers #41 and #40 (Table 1) ; (ii) Q300, representing to the Q2 3′ 308 nt sequence was amplified by PCR using primers #39 and #40; (iii) Fny-CMV probe, representing to the 3′ 90 nt sequence of Fny-CMV RNA3 (F3) was amplified by PCR using primers # 42 and #43 and (iv) BMV riboprobe, representing the BMV RNA3 nt 1911-2111, was described previously (Rao and Grantham, 1994) . 32 Plabelled DNA probes were made using a Prime-a-gene kit (Promega) according to the manufacturer's instructions. Hybridizations were performed at 65°C using buffer conditions as described previously (Sambrook and Russell, 2001) .
Sequencing the 5′ end of RNA5
The 5′ end sequence of RNA5 produced from Q1, Q2 and Q3 was determined using a 5′RACE kit according to the manufacturer's instructions (Roche) using a gene specific primer SP1 (primer # 47) and nested primer SP2 (primer # 48) (Table 1) on each total RNA preparation.
RT-PCR and cloning
RT-PCR was performed on RNA samples using a Protoscript II RT-PCR kit from New England Biolabs, according to the manufacturer's instructions. As a negative control to exclude the possibility that recombination was an artifact of RT-PCR we mixed the following RNAs: (i) Q-CMV RNAs 1, 2 and 5 produced from agroinfiltration of Q1 + Q2 on N. benthamiana leaves and (ii) an RNA3 produced from in vitro transcription of a PCR product amplified from pCASS.Rz-Q3B3 using primers #50 and #40 (Table 1 ). In vitro transcription was performed using a T7 transcription kit from Promega according to the manufacturer's instructions. RT-PCR products were subsequently cloned into the Promega pGEM-T easy vector according to the manufacturer's instructions. Cloned DNA was analyzed by sequencing.
